The chapter delves into the impact of genetic testing on insurance coverage, highlighting the protection provided by the Genetic Information Non-Discrimination Act (GINA) in terms of health insurance but noting the lack of restrictions for life insurance companies. It discusses the importance of early screening for genetic conditions and personalized medicine, emphasizing the significance of genetic information for proactive health management and mitigating risks for genetic diseases in children.
Noor Siddiqui is currently building Orchid, a reproductive technology company that measures genetic predisposition to disease and provides embryo screening for couples going through IVF.
Noor joins the show to discuss the ambitious culture of the West Coast, getting into the Thiel Fellowship, her personal reasons for starting Orchid, the sacred act of reproduction and why it must be made safe, her belief in children as the future, and MUCH more!
Important Links:
Show Notes:
- The Ambitious Culture of San Francisco
- The East Coast Aversion to Risky Ambition
- The Intimate Origin Story of Orchid
- What Orchid Has Built
- The History and Controversy Around Reproductive Technology
- Surprising Aspects of Orchid’s Technology
- Benefits of Saliva Testing
- Making Our Own Genetic Luck
- Noor’s Predictions for the Field
- Advances in Embryonic Freezing
- Why Noor Values Clear Writing
- Noor as Empress of the World
- MORE!
Books/Essays Mentioned: